Capital Management’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Sell
1,878,411
-563,508
-23% -$3.41M 1.76% 24
2026
Q1
$10.5M Buy
2,441,919
+307,345
+14% +$1.61M 1.8% 23
2025
Q4
$13.1M Buy
2,134,574
+70,398
+3% +$521K 2.16% 19
2025
Q3
$20.1M Buy
2,064,176
+798,066
+63% +$9.99M 3.16% 10
2025
Q2
$16.6M Buy
1,266,110
+550,607
+77% +$7.12M 2.82% 13
2025
Q1
$10.4M Buy
715,503
+413,918
+137% +$7.81M 1.81% 25
2024
Q4
$5.29M Sell
301,585
-118,345
-28% -$1.66M 0.95% 42
2024
Q3
$5.07M Buy
+419,930
New +$3.48M 0.9% 42

Other funds holding LFVN

Capital Management's LFVN Position: Q2 2026 in Review

Capital Management reduced its LifeVantage (LFVN) stake by 23% in Q2 2026, selling an estimated $3.41M and leaving 1,878,411 shares worth $11.7M. The position accounts for 1.76% of the portfolio, ranked #24.

Capital Management first reported a position in LFVN in Q3 2024 and has held it in 8 quarters since. The position peaked at $20.1M in Q3 2025. 89 funds tracked by Wall St. Rank hold LFVN as of Q2 2026.

  • Capital Management held 1,878,411 shares of LifeVantage worth $11.7M as of Q2 2026.
  • Capital Management sold 563,508 LifeVantage shares in Q2 2026, an estimated $3.41M.
  • LifeVantage made up 1.76% of Capital Management's portfolio in Q2 2026, its #24 holding.
  • Capital Management first reported a position in LifeVantage in Q3 2024 and has held it in 8 quarters since.
  • Capital Management's LifeVantage position peaked at $20.1M in Q3 2025.
  • 89 funds tracked by Wall St. Rank held LifeVantage as of Q2 2026.

Based on Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.